Cost-effectiveness analysis of primary treatments for localised prostate cancer: A population-based Markov analysis using real-world evidence.

Xiuhua WengLixian ZhongPin XiangYiyuan LiAlan PaciorekLiangliang DongJeanette BroeringPeter R CarrollMartin SandaLeslie Wilson

Published in: European journal of cancer care (2022)

This first CEA combining prospective real-world evidence for HRQOL outcomes with costs shows cost-effectiveness of treatments vary by risk groups, providing new evidence for treatment decisions.

Keyphrases

prostate cancer
radical prostatectomy
type diabetes
metabolic syndrome
combination therapy
smoking cessation